F-1/A: Glamoore Capital Group Seeks $8 Million in Nasdaq IPO Amid Regulatory Scrutiny

Glamoore Capital Group, a Hong Kong-based financial services firm, aims to raise capital through a U.S. IPO while navigating regulatory uncertainties and risks associated with operating in Hong Kong and China.

Summary

• Glamoore Capital Group, a Cayman Islands-incorporated company with operations in Hong Kong, is planning an initial public offering (IPO) on the Nasdaq Capital Market.
• The company intends to offer 2,000,000 Ordinary Shares, with selling shareholders offering an additional 1,750,000 shares, at an expected price of $4 per share.
• The IPO aims to raise $8 million in gross proceeds for the company, while the selling shareholders will receive proceeds from their share sales.
• The company plans to use the net proceeds to strengthen its corporate finance and placing/underwriting businesses, enhance asset management services, expand its brand and office operations, and for general corporate purposes.
• The offering is contingent upon Nasdaq listing approval, and the company has applied to list its shares under the symbol GMCG.
• The document highlights significant risks associated with operating in Hong Kong, including potential intervention by the PRC government, regulatory uncertainties, and data security concerns.
• The company acknowledges the risk of potential regulatory changes in China and their impact on Hong Kong-based issuers.
• The document also mentions the Holding Foreign Companies Accountable Act (HFCA Act) and the potential delisting of shares if the company's auditor cannot be inspected by the PCAOB.
• The company's principal shareholders will retain significant voting power post-IPO, potentially influencing management decisions.
• The company is an emerging growth company and a foreign private issuer, which allows for reduced reporting requirements.
• The company's key operations are in Hong Kong, making it subject to economic and political risks in the region.
• The company relies on dividends from its subsidiaries to fund its cash requirements, which could be affected by restrictions on their ability to pay dividends.
• The company acknowledges the risk of potential conflicts of interest and the need for effective internal controls.
• The company is exposed to potential disruptions and risks from unforeseen disasters or crises.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it highlights the company's strengths and growth strategies, it also emphasizes significant risks and regulatory uncertainties, particularly those related to operating in Hong Kong and China. The financial results show a recent shift from profit to loss, which further tempers the overall sentiment.

Positives

• The company has an established reputation and market presence in the financial services industry.
• The Operating Subsidiaries have an experienced management team and a well-qualified professional workforce.
• The company has established and strong relationships with clients and a stable client base.
• The company has a strong regulatory compliance and risk management framework.
• The company is an emerging growth company and a foreign private issuer, allowing for reduced reporting requirements.

Negatives

• The company's operations are concentrated in Hong Kong, making it susceptible to economic and political conditions in the region.
• The company is subject to regulatory changes relevant to companies listed on the Hong Kong Stock Exchange and other exchanges.
• The company is exposed to business risk arising from its placing and underwriting business.
• The company's asset management business may be adversely affected by poor investment performance and market competition.
• The company relies on a limited number of key clients for its business, exposing it to significant client concentration risk.
• The company may be subject to substantial risks if clients using its securities dealing and brokerage services default on or delay payments.
• The company's lack of effective internal controls over financial reporting may affect its ability to accurately report financial results or prevent fraud.
• The company may be unable to successfully implement its future business plans and objectives.

Risks

• The Operating Subsidiaries operate in a highly regulated industry and ongoing compliance with the rules and regulations could be costly and affect our operations.
• Our operations are concentrated in Hong Kong. Our business performance is highly influenced by the conditions of capital and financial market in Hong Kong and globally.
• The Operating Subsidiaries are susceptible to regulatory changes relevant to companies listed on the Hong Kong Stock Exchange and other exchanges.
• Where one or more of the regulated activities of the Operating Subsidiaries has less than two responsible officers, the relevant Operating Subsidiaries will be in breach of the relevant licensing requirements which could adversely affect the license status of the Operating Subsidiaries, thus jeopardizing our business and financial performance.
• The revenue from our corporate finance and capital market advisory services and our placing and underwriting business is non-recurring in nature and our profitability is highly unpredictable.
• We are exposed to business risk arising from our placing and underwriting business in case the securities underwritten by the Operating Subsidiaries are undersubscribed or placing exercise fails to complete.
• Our asset management business may be adversely affected by the risks arising from poor investment performance and market competition which could significantly decrease our AUM.
• Our key operations are in Hong Kong, a Special Administrative Region of the PRC. According to the long-arm provisions of the current PRC laws and regulations, the PRC government may exercise significant oversight and discretion over the conduct of our business and may intervene in or influence our operations at any time, which could result in a material change in our operations and/or the value of the Shares.
• There are uncertainties regarding the interpretation and enforcement of PRC and Hong Kong laws, rules, and regulations.
• Adverse regulatory developments in China may subject us to additional regulatory review, and additional disclosure requirements and regulatory scrutiny to be adopted by the SEC in response to risks related to recent regulatory developments in China may impose additional compliance requirements for companies like us with Hong Kong-based operations, all of which could increase our compliance costs and subject us to additional disclosure requirements.
• We may become subject to a variety of PRC laws and other obligations regarding data security offerings that are conducted overseas and/or foreign investment in China-based issuers, and any failure to comply with applicable laws and obligations could have a material and adverse effect on our business, financial condition and results of operations and may hinder our ability to offer or continue to offer Ordinary Shares to investors and cause the value of the Shares to significantly decline or be worthless.
• If the PRC government chooses to extend the oversight and control over offerings that are conducted overseas and/or foreign investment in mainland China-based issuers to Hong Kong-based issuers, such action may significantly limit or completely hinder our ability to offer or continue to offer Ordinary Shares to investors and cause the value of our Ordinary Shares to significantly decline or be worthless.
• Although the audit report included in this prospectus is prepared by U.S. auditors who are currently inspectable by the PCAOB, there is no guarantee that future audit reports will be prepared by auditors inspectable by the PCAOB and, as such, in the future investors may be deprived of the benefits of the PCAOB inspection program. Furthermore, trading in our securities may be prohibited under the HFCA Act if the SEC subsequently determines our audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely, and as a result, U.S. national securities exchanges, such as the Nasdaq, may determine to delist our securities. Furthermore, on December 29, 2022, the Accelerating Holding Foreign Companies Accountable Act was enacted, which amended the HFCA Act by requiring the SEC to prohibit an issuers securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three, and thus reduced the time before the Shares may be prohibited from trading or delisted.
• The recent joint statement by the SEC, proposed rule changes submitted by Nasdaq, and an act passed by the U.S. Senate and the U.S. House of Representatives all call for additional and more stringent criteria to be applied to emerging market companies. These developments could add uncertainties to our offering, business operations, share price, and reputation.
• We rely on dividends and other distributions on equity paid by our subsidiaries to fund our cash and financing requirements we may have, and any limitation on the ability of our subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business.
• Our lack of effective internal controls over financial reporting may affect our ability to accurately report our financial results or prevent fraud, which may affect the market for and the price of the Shares.
• If we fail to meet applicable listing requirements, Nasdaq may delist the Shares from trading, in which case the liquidity and market price of the Shares could decline.
• If you purchase the Shares in this offering, you will incur immediate and substantial dilution in the book value of your Shares.
• If a limited number of participants in this offering purchase a significant percentage of the offering, the effective public float may be smaller than anticipated and the price of the Shares may be more volatile than it otherwise would be.

Future Outlook

The company intends to pursue strategies to enhance existing business capabilities, strengthen placing and underwriting services, broaden client network, and enhance asset management services.

Industry Context

The document provides background on the financial and wealth management industry in Hong Kong, including the roles of licensed corporations and registered institutions, and the regulatory landscape.

Comparison to Industry Standards

• The document mentions that the numbers of newly listed companies on the Main Board and GEM, in aggregate, for the years ended December 31, 2022 and 2023, respectively, are the lowest among the numbers for each of the year from 2014 to 2023, being a time period of approximately a decade.
• According to annual statistics of the Hong Kong Stock Exchange, total equity funds raised dropped from approximately US$32 billion for the year ended December 31, 2022 to approximately US$19 billion for the year ended December 31, 2023, and the number of newly listed companies decreased from 90 for the year ended December 31, 2022 to 73 for the year ended December 31, 2023, among which the number of companies newly listed on the Main Board decreased from 90 to 73, and the number of companies newly listed on GEM remained at 0 for the respective years.

Legal Proceedings

• On June 2, 2023, the SFC has commenced an investigation under the SFO against GCL and two of its responsible officers, Mr. Chu Chun Yi and Mr. Chow Ka Keung.

Related Party Transactions

• On November 5, 2024, the Company, Mr. Law, and certain related parties entered into offsetting arrangement to net off the amount due from Mr. Law (in the amount of HK$2,738,736) and the corresponding amount due to Active Ideal as of November 5, 2024.
• On November 6, 2024, the Company, Mr. Yeung and certain related parties entered into offsetting arrangement to net off the amount due from Mr. Yeung (in the amount of HK$5,373,643) and the amount due to Team Plus International Limited as of November 6, 2024 (in the amount of HK$4,019,039).

Stakeholder Impact

• The document outlines potential impacts on shareholders, including dilution, market volatility, and the influence of principal shareholders.
• The document also discusses the impact of COVID-19 on the company's business and operations.

Next Steps

• The company has applied to have the Shares listed on the Nasdaq Capital Market under the symbol GMCG.
• The Underwriters expect to deliver the Ordinary Shares against payment as set forth under Underwriting on or about , 2025.

Key Dates

Keywords

IPO, Glamoore Capital Group, Nasdaq, financial services, Hong Kong, regulatory risks, PCAOB, HFCA Act, securities, investment, China, offering, underwriting, capital markets, compliance